Cancer Genetics (CGIX) Announces Shareholder Approval of All Proposals in Connection with the Proposed Merger with StemoniX Mar 25, 2021 09:17AM
Cancer Genetics Announces Shareholder Approval of All Proposals in Connection with the Proposed Merger with StemoniX Mar 25, 2021 09:15AM
Cancer Genetics Announces Shareholder Approval of All Proposals in Connection with the Proposed Merger with StemoniX Mar 25, 2021 09:15AM
Cancer Genetics Announces Roland J. Carrillo, PhD as Vice President of Business Development Mar 18, 2021 08:30AM
Cancer Genetics Announces Roland J. Carrillo, PhD as Vice President of Business Development Mar 18, 2021 08:30AM
View Older Stories

Mar 12, 2021 09:30AM Cancer Genetics to Present at the Annual 33rd ROTH Conference
Mar 12, 2021 09:30AM Cancer Genetics to Present at the Annual 33rd ROTH Conference
Mar 4, 2021 04:15PM Cancer Genetics to Present at the H.C. Wainwright Global Life Sciences Conference
Mar 4, 2021 04:15PM Cancer Genetics to Present at the H.C. Wainwright Global Life Sciences Conference
Jan 7, 2021 04:05PM Cancer Genetics to Present at the 2021 BioConnect Virtual Conference Hosted by H.C. Wainwright
Jan 7, 2021 04:05PM Cancer Genetics to Present at the 2021 BioConnect Virtual Conference Hosted by H.C. Wainwright
Nov 12, 2020 04:25PM Cancer Genetics Reports Third Quarter 2020 Financial Results
Nov 12, 2020 04:25PM Cancer Genetics Reports Third Quarter 2020 Financial Results
Sep 10, 2020 08:00AM Cancer Genetics Announces Participation at the 22nd Annual Rodman & Renshaw Global Investment Conference
Sep 10, 2020 08:00AM Cancer Genetics Announces Participation at the 22nd Annual Rodman & Renshaw Global Investment Conference
Sep 3, 2020 08:00AM Cancer Genetics and StemoniX Announce Joint Proof-of-Concept Program
Sep 3, 2020 08:00AM Cancer Genetics and StemoniX Announce Joint Proof-of-Concept Program
Aug 24, 2020 08:01AM Cancer Genetics (CGIX) and StemoniX Sign Definitive Agreement to Merge
Aug 24, 2020 08:00AM Cancer Genetics and StemoniX Sign Definitive Agreement to Merge
Aug 24, 2020 08:00AM Cancer Genetics and StemoniX Sign Definitive Agreement to Merge
Aug 14, 2020 07:30AM Cancer Genetics Reports Second Quarter 2020 Financial Results
Aug 14, 2020 07:30AM Cancer Genetics Reports Second Quarter 2020 Financial Results
Jun 24, 2020 05:30PM Cancer Genetics Reports First Quarter 2020 Financial Results and Provides Strategic Business Updates
Jun 24, 2020 05:30PM Cancer Genetics Reports First Quarter 2020 Financial Results and Provides Strategic Business Updates
Jun 1, 2020 08:00AM Cancer Genetics Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Strategic Business Updates
Jun 1, 2020 08:00AM Cancer Genetics Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Strategic Business Updates
May 20, 2019 05:00PM Cancer Genetics Reports First Quarter 2019 Financial Results and Provides Strategic Business Update
Apr 16, 2019 07:00AM Cancer Genetics Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Strategic Business Updates
Jan 16, 2019 08:45AM Cancer Genetics Issues Letter to Shareholders
Jan 10, 2019 09:29AM Pre-Open Stock Movers 01/10: (DCIX) (VERI) (BBBY) Higher; (M) (MDB) (KSS) Lower (more...)
Jan 9, 2019 08:00AM Cancer Genetics Strengthens Management Team with Appointment of William Finger as Executive Vice President, Precision Medicine and Pharma Services
Dec 17, 2018 08:03AM Cancer Genetics (CGIX) Terminates Proposed Merger with NovellusDx
Dec 17, 2018 08:00AM Cancer Genetics Terminates Proposed Merger with NovellusDx
Nov 19, 2018 04:16PM Cancer Genetics Reports Third Quarter 2018 Financial Results and Provides Strategic Business Updates
Oct 18, 2018 09:09AM Cancer Genetics (CGIX) Announces Strategic Partnership with Genecast Biotechnology to Commercialize Tissue of Origin Test in China
Oct 18, 2018 09:05AM Cancer Genetics Enters Strategic Partnership with Genecast Biotechnology to Commercialize Tissue of Origin® Test in China
Oct 8, 2018 07:00AM Cancer Genetics and Cellaria Partner on Precision Medicine Tools
Sep 25, 2018 04:03PM Cancer Genetics (CGIX) Enters Supply Agreement with Agilent Technologies (A)
Sep 25, 2018 04:01PM Cancer Genetics Enters Supply Agreement with Agilent Technologies
Sep 20, 2018 08:30AM Cancer Genetics Offers Oncomine Comprehensive Assay to Drive Clinical Trials
Sep 18, 2018 08:32AM Cancer Genetics (CGIX) and NovellusDx Enter Definitive Agreement to Merge
Sep 18, 2018 08:30AM Cancer Genetics and NovellusDx Sign Definitive Agreement to Merge
Aug 14, 2018 07:30AM Cancer Genetics Reports Second Quarter 2018 Financial Results and Provides Strategic Business Updates
Aug 7, 2018 04:05PM Cancer Genetics to Report Second Quarter 2018 Financial Results on August 14, 2018
Jul 18, 2018 04:05PM Cancer Genetics Closes $2.625 million Convertible Note Financing
Jun 12, 2018 08:00AM Cancer Genetics Strengthens Management Team with Appointment of Michael McCartney as Chief Commercial Officer
May 15, 2018 07:00AM Cancer Genetics Reports First Quarter 2018 Financial Results and Provides Strategic Business Updates
May 10, 2018 04:05PM Cancer Genetics to Report First Quarter 2018 Financial Results on May 15, 2018
Apr 27, 2018 08:33AM Cancer Genetics (CGIX) Reports Sale of India Operations to REPROCELL Inc. for $1.9M
Apr 27, 2018 08:30AM Cancer Genetics Announces Sale of India Operations to REPROCELL Incorporated
Apr 16, 2018 07:30AM Cancer Genetics' (CGIX) Tissue of Origin Test Receives Special FDA 510(k) Clearance
Apr 16, 2018 07:30AM Cancer Genetics’ Unique Tissue of Origin Test (TOO®) Receives Special FDA 510(k) Clearance
Apr 2, 2018 04:01PM Cancer Genetics Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Strategic Business Updates
Mar 26, 2018 07:30AM Cancer Genetics to Host Fourth Quarter and Full Year 2017 Financial Results  
Mar 14, 2018 10:32AM PierianDx Announces Partnership with Cancer Genetics to Provide Comprehensive Precision Oncology Testing and Workflow Solution
View Older Stories